SEC Form D filing

Delfi Diagnostics, Inc., 2025-12-18

An SEC Form D private-offering notice from Palo Alto, CA, a $60,000,000 filer-stated offering target in Biotech. Filed 2025-12-18. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Delfi Diagnostics, Inc. site↗ Verified via SEC Form D

Develops blood based tests that analyze DNA fragmentation patterns for early cancer detection, including its FirstLook Lung screening test.

Filed 2025-12-18Filed to raise $60,000,000First money in 2025-12-01Raised so far $34,333,315HQ (as filed) Palo Alto, CASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Debt-only offering
Source linked the Form D on EDGAR↗Website verified delfidiagnostics.com↗Named in the filing 11 executives & directors
Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source